PositiveID, formerly VeriChip, sells a human-implantable RFID microchip to identify persons arriving in the emergency room and enable access to a personal health record. The company is developing an implantable microchip to measure glucose levels and the new acquisition expands its scope of diabetes management services.
Easy Check is developing a breath test to measure glucose levels, and a wireless text messaging system to transmit glucose readings to a secure Web database.
More information is available at positiveidcorp.com.
--Joseph Goedert
Be the first to comment on this post using the section below.